Stay updated on SUSTAIN: Semaglutide vs Sitagliptin in Type 2 Diabetes Clinical Trial

Sign up to get notified when there's something new on the SUSTAIN: Semaglutide vs Sitagliptin in Type 2 Diabetes Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SUSTAIN: Semaglutide vs Sitagliptin in Type 2 Diabetes Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page now displays Revision: v3.3.4, replacing Revision: v3.3.3.
    Difference
    0.0%
    Check dated 2026-01-14T01:12:47.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The Study Locations were updated: new site listings across Brazil (Goiás, Rio Grande do Sul, São Paulo), China (Anhui, Beijing Municipality, Chongqing, Fujian, Guangdong, Guizhou, Heilongjiang, Hunan, Jiangsu, Jiangxi, Jilin, Liaoning, Ningxia, Shaanxi, Shandong, Shanghai Municipality, Shanxi, Tianjin Municipality, Yunnan), and South Africa (Gauteng, KwaZulu-Natal). The previous location sections were removed.
    Difference
    1%
    Check dated 2025-12-23T21:27:31.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    New clarifications were added to the Publications section indicating that publications may be provided voluntarily and are auto-filled from PubMed. The revision label was updated from v3.2.0 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-25T13:51:09.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Removed the site-wide banner about government funding and operating status. The study details, eligibility criteria, and results information remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-18T07:23:10.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    Core study data such as title, arms, outcomes, and locations appear unchanged; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-03T21:30:26.000Z thumbnail image
  8. Check
    101 days ago
    Change Detected
    Summary
    Major update adds a government-status notice and upgrades version to v3.2.0; previous v3.1.0 reference removed.
    Difference
    1.0%
    Check dated 2025-10-06T06:39:23.000Z thumbnail image

Stay in the know with updates to SUSTAIN: Semaglutide vs Sitagliptin in Type 2 Diabetes Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SUSTAIN: Semaglutide vs Sitagliptin in Type 2 Diabetes Clinical Trial page.